Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to -$49.0 million.

  • Bio-Techne's Cash from Financing Activities rose 4157.0% to -$49.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$251.7 million, marking a year-over-year decrease of 2105.05%. This contributed to the annual value of -$253.9 million for FY2025, which is 10744.21% down from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Cash from Financing Activities is -$49.0 million, which was up 4157.0% from -$44.2 million recorded in Q3 2025.
  • Bio-Techne's Cash from Financing Activities' 5-year high stood at $150.8 million during Q1 2023, with a 5-year trough of -$90.5 million in Q2 2025.
  • Its 5-year average for Cash from Financing Activities is -$31.4 million, with a median of -$52.9 million in 2021.
  • Per our database at Business Quant, Bio-Techne's Cash from Financing Activities skyrocketed by 36316.64% in 2021 and then tumbled by 28202.4% in 2025.
  • Bio-Techne's Cash from Financing Activities (Quarter) stood at -$53.4 million in 2021, then crashed by 35.26% to -$72.2 million in 2022, then fell by 12.75% to -$81.4 million in 2023, then fell by 3.0% to -$83.8 million in 2024, then surged by 41.57% to -$49.0 million in 2025.
  • Its Cash from Financing Activities was -$49.0 million in Q4 2025, compared to -$44.2 million in Q3 2025 and -$90.5 million in Q2 2025.